443 related articles for article (PubMed ID: 12546894)
1. Structure-based virtual screening: an overview.
Lyne PD
Drug Discov Today; 2002 Oct; 7(20):1047-55. PubMed ID: 12546894
[TBL] [Abstract][Full Text] [Related]
2. Recent development and application of virtual screening in drug discovery: an overview.
Hou T; Xu X
Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
[TBL] [Abstract][Full Text] [Related]
3. Life in the fast lane: high-throughput chemistry for lead generation and optimisation.
Hunter D
J Cell Biochem Suppl; 2001; Suppl 37():22-7. PubMed ID: 11842424
[TBL] [Abstract][Full Text] [Related]
4. Synergies of virtual screening approaches.
Muegge I
Mini Rev Med Chem; 2008 Aug; 8(9):927-33. PubMed ID: 18691150
[TBL] [Abstract][Full Text] [Related]
5. From in vivo to in vitro/in silico ADME: progress and challenges.
Van de Waterbeemd H
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
[TBL] [Abstract][Full Text] [Related]
6. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
7. Computational chemistry as an integral component of lead generation.
Roche O; Guba W
Mini Rev Med Chem; 2005 Jul; 5(7):677-83. PubMed ID: 16026314
[TBL] [Abstract][Full Text] [Related]
8. Current status of virtual screening as analysed by target class.
Stoermer MJ
Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359
[TBL] [Abstract][Full Text] [Related]
9. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
10. High throughput assay technologies for ion channel drug discovery.
Zheng W; Spencer RH; Kiss L
Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
[TBL] [Abstract][Full Text] [Related]
11. From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.
Willmann S; Lippert J; Schmitt W
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):159-68. PubMed ID: 16922658
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening: an endless staircase?
Schneider G
Nat Rev Drug Discov; 2010 Apr; 9(4):273-6. PubMed ID: 20357802
[TBL] [Abstract][Full Text] [Related]
13. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening for the discovery of bioactive natural products.
Rollinger JM; Stuppner H; Langer T
Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
[TBL] [Abstract][Full Text] [Related]
15. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
Tanrikulu Y; Schneider G
Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
[TBL] [Abstract][Full Text] [Related]
16. [High throughput screening in the process of drug discovery].
Ueki T
Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):276-80. PubMed ID: 17435340
[No Abstract] [Full Text] [Related]
17. Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.
Ma XH; Jia J; Zhu F; Xue Y; Li ZR; Chen YZ
Comb Chem High Throughput Screen; 2009 May; 12(4):344-57. PubMed ID: 19442064
[TBL] [Abstract][Full Text] [Related]
18. Fragonomics: fragment-based drug discovery.
Zartler ER; Shapiro MJ
Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Development of Novel Drugs.
Erakovic Haber V; Spaventi R
Prog Mol Subcell Biol; 2017; 55():91-104. PubMed ID: 28238036
[TBL] [Abstract][Full Text] [Related]
20. Targeted scoring functions for virtual screening.
Seifert MH
Drug Discov Today; 2009 Jun; 14(11-12):562-9. PubMed ID: 19508918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
